Speakers from across Europe in the healthcare, industrial and agricultural sectors communicated their views on how biotechnology is creating more jobs, improving lives and building a greener and healthier society at a EuropaBio event in Brussels last week.
They outlined how biotechnology is translating into to benefits in major areas of concern for European citizens, including healthy living and ageing, climate change and food and energy security.
EuropaBio Chairman Andrea Rappagliosi told the meeting, “Biotechnology has the potential to help make Europe a world-class science performer, providing smart, sustainable and inclusive solutions for citizens, patients and consumers for 2020 and beyond.”
“Our industry is willing to be held accountable for delivering products and services that have a demonstrable value, in order to retain and strengthen state-of-the-art research and development in Europe. We are committed to playing our role in this process together with regulators, civil society and a broad range of stakeholders.”
In the keynote address, EU Health Commissioner John Dalli, said, “Efforts by industry must be underpinned by a predictable regulatory environment and legal certainty for operators,” adding that the, “European biotechnology industry has been a leader worldwide, from its research and development capacity to its success in diffusing these innovations globally.”
Receive the Funding Newswire each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening. 
Follow where the public and private R&I money is going and which collaborative opportunities you can pursue.
